Olipudasa alfa ((XenpozymeTM) para la deficiencia de esfingomielinasa ácida
Olipudasa alfa ((XenpozymeTM) para la deficiencia de esfingomielinasa ácida
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1402184
Olipudasa alfa ((XenpozymeTM) para la deficiencia de esfingomielinasa ácida
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1402184
FDA Roundup: Dec. 13, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-dec-13-2022
FDA Roundup: December 13, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-13-2022
http://www.fda.gov/medical-devices/letters-health-care-providers/2020-letters-health-care-providers
FDA Roundup: December 9, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-9-2022
Coronavirus (COVID-19) Update: FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-updated-bivalent-covid-19-vaccines-children-down-6-months
FDA Roundup: December 6, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-6-2022